CPRX β€” CATALYST PHARMACEUTICALS INC

Ownership history in XTX MARKETS LLC  Β·  1 quarter on record

This page tracks every 13F SEC filing in which XTX MARKETS LLC reported a position in CATALYST PHARMACEUTICALS INC (CPRX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β€” sourced directly from SEC EDGAR 13F filings.

πŸ” Peak position
0.27% (2020 Q3)
πŸ“Š Avg. % of fund
0.27%
πŸ“… First filed
2020 Q3
πŸ“… Last filed
2020 Q3
⏱ Quarters held
1
% of Fund (quarterly)    CPRX price (monthly, adj. close)
πŸ“‹ Quarterly Holdings History 1 quarter  β–Ύ
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2020 Q3 INITIATED 18,749 β€” β€” 0.27% $56K $2.97

🏒 Other funds also holding CPRX

As of 2025 Q4 β€” sorted by position size

TANAKA CAPITAL MANAGEMENT INC 3Y 7Y 4.87% GABLES CAPITAL MANAGEMENT INC. 3Y 7Y 4.19% JW Asset Management, LLC 3Y 7Y 2.95% Knott David M Jr 3Y 2.04% DEERFIELD MANAGEMENT COMPANY, L.P. 3Y 7Y 1.46% QSV Equity Investors LLC 1.24% Bridge City Capital, LLC 3Y 7Y 1.07% GLOBEFLEX CAPITAL L P 3Y 7Y 1.04% JUNCTURE WEALTH STRATEGIES, LLC 3Y 7Y 0.65% KENNEDY CAPITAL MANAGEMENT LLC 3Y 7Y 0.6%
← Back to XTX MARKETS LLC Holdings